When rheumatoid arthritis meets malignancy, what do we do?

Int J Rheum Dis. 2024 Mar;27(3):e15095. doi: 10.1111/1756-185X.15095.

Authors

Yixuan Li^{1

2

3}, Jing Wang^{1

2

3}, Ju Zhang^{2

3}, Huan Jiang^{1

2

3}, Aihui Liu^{2

3}, Zhenhua Ying^{2

3}

Affiliations

¹ Zhejiang Chinese Medical University, Hangzhou, China.
² Center for General Practice Medicine, Department of Rheumatology and Immunology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
³ Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation for Arthritis Diagnosis and Treatment, Hangzhou, China.

PMID: 38439191
DOI: 10.1111/1756-185X.15095

No abstract available

Publication types

Letter